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Dose reconstructiona b s t r a c t
Background and purpose: Anatomical changes during external beam radiotherapy prevent the accurate
delivery of the intended dose distribution. Resolving the delivered dose, which is currently unknown,
is crucial to link radiotherapy doses to clinical outcomes and ultimately improve the standard of care.
Material and methods: In this study, we present a dose reconstruction workflow based on data routinely
acquired during MR-guided radiotherapy. It employs 3D MR images, 2D cine MR images and treatment
machine log files to calculate the delivered dose taking intrafractional motion into account. The devel-
oped pipeline was used to measure anatomical changes and assess their dosimetric impact in 89 prostate
radiotherapy fractions delivered with a 1.5 T MR-linac at our institute.
Results: Over the course of radiation delivery, the CTV shifted 0.6 mm ± 2.1 mm posteriorly and 1.3 m
m ± 1.5 mm inferiorly. When extrapolating the dose changes in each case to 20 fractions, the mean clin-
ical target volume D98% and clinical target volume D50% dose-volume metrics decreased by 1.1 Gy ± 1.6 Gy
and 0.1 Gy ± 0.2 Gy, respectively. Bladder D3% did not change (0.0 Gy ± 1.2 Gy), while rectum D3%
decreased by 1.0 Gy ± 2.0 Gy. Although anatomical changes and their dosimetric impact were small in
the majority of cases, large intrafractional motion caused the delivered dose to substantially deviate from
the intended plan in some fractions.
Conclusions: The presented end-to-end workflow is able to reliably, non-invasively and automatically
reconstruct the delivered prostate radiotherapy dose by processing MR-linac treatment log files and
online MR images. In the future, we envision this workflow to be adapted to other cancer sites and ulti-
mately to enter widespread clinical use.
 2019 The Authors. Published by Elsevier B.V. Radiotherapy and Oncology 145 (2020) 88–94 This is an
open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).The clinical workflow to deliver external beam radiotherapy
begins with the acquisition of anatomical and functional images
of the patient [1]. Based on this information a treatment plan is
designed, aiming to deliver a lethal amount of radiation to the
tumor while sparing nearby organs-at-risk. In reality, the intended
dose distribution is never delivered and the actually administered
dose is unknown as the patient’s anatomy changes over the course
of treatment. Tumor and organ movement, caused by respiratory,
cardiac and gastrointestinal activity, result in underdosage of the
tumor and unwanted exposure of healthy organs-at-risk [2–4].
Measuring anatomical changes and their impact on the delivered
dose is crucial to accurately link the radiation dose distribution
to the treatment’s therapeutic effect [5]. Improving this under-
standing is necessary to further optimize radiotherapy deliveries,inform patient stratification and ultimately drive the development
and implementation of real-time adaptive radiotherapy
techniques.
Radiotherapy treatment machines with integrated MR imaging
are able to continuously survey the patient undergoing treatment
without the need for implanted markers or additional imaging
dose [6–9]. They facilitate adaptation of the treatment to interfrac-
tional anatomical changes based on MR images acquired before the
delivery of each fraction [10,11]. On-board MR imaging can also be
deployed to monitor intrafractional tumor motion and adapt the
treatment in real-time using treatment beam gating [12–15]. How-
ever, we are not aware of any studies reporting the use of online
MR imaging to determine the delivered dose while accounting
for intrafractional anatomical changes. This study presents a
workflow that processes 3D MR images, 2D cine MR images and
MR-linac machine log files to reconstruct the delivered dose. We
measured intrafractional motion of the prostate and reconstructed
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tered with the Elekta Unity 1.5 T MR-linac (Elekta AB, Stockholm,
Sweden) at our institute.Material and methods
Clinical MR-guided prostate radiotherapy protocol
At our institute, prostate cancer patients are treated with the
Unity 1.5 T MR-linac as part of the PRISM trial [16]. We aim to deli-
ver 60 Gy in 20 fractions to the primary clinical target volume
(CTV), comprising the entire prostate and the adjacent 1 cm of
the seminal vesicles. Simultaneously, a secondary CTV, defined as
the 2 cm of the seminal vesicles proximal to the primary CTV, is
treated to 48.6 Gy. Additional planning constraints can be found
in the Supplementary material.
The original fully optimized seven-beam intensity modulated
radiotherapy (IMRT) treatment plan for the Unity MR-linac is gen-
erated on a pre-treatment CT image using the Elekta Monaco treat-
ment planning system, version 5.40.00. At each fraction, the
patient is positioned on the MR-linac treatment couch and a 3D
T2-weighted MR planning image is acquired (sequence parameters
in the Supplementary material). All contours are mapped from the
pre-treatment image to the MR image via deformable image regis-
tration. An expert physician corrects the propagated CTV and crit-
ical organ-at-risk contours as needed. In order to calculate the dose
on the MR image, bulk electron densities are assigned to the vol-
umes defined by the contours [17]. The primary planning target
volume (PTV) is created by expanding the primary CTV isotropi-
cally by 5 mm, except in posterior direction, where a 3 mmmargin
is added. The secondary PTV is generated by expanding the union
of both CTVs by 5 mm.
Based on the updated contours, Monaco re-optimizes the treat-
ment plan using the optimization constraints derived for the orig-
inal treatment plan (‘‘adapt-to-shape”) [18]. After contouring and
re-planning, a 3D MR verification image is acquired. If the prostate
has moved outside of the PTV during the previous steps, the treat-
ment plan is adapted once more using the segment aperture mor-
phing algorithm (‘‘adapt-to-position”) [19].
During dose delivery, the patient is continuously monitored
using a T2/T1-weighted balanced steady-state free precession MR
sequence (parameters in the Supplementary material). The
sequence images three orthogonal planes in cyclic order (transver-
sal then sagittal then coronal) with an update frequency of 1.63 Hz
for each plane. The acquired sagittal, coronal and transversal imag-
ing planes intersect at the center of the target’s bounding box (de-
fined as the smallest rectangular prism that encompasses the PTV
while being aligned with the main patient axes). Additionally, the
MR-linac dose delivery status is recorded every 40 ms in a treat-
ment machine log file.Measurement of intrafractional prostate motion
In the context of the described workflow, we defined intrafrac-
tional motion as any anatomical changes occurring after the verifi-
cation image has been obtained and the final treatment plan has
been approved. In order to quantify the intrafractional motion,
we were presented with two distinct image processing tasks: 1)
determining the anatomical changes occurring between the acqui-
sition of the 3D verification image and the beginning of 2D cine MR
imaging and 2) monitoring the motion during radiation delivery
while we survey the patient via 2D cine MR imaging.
For this study, we aimed at detecting shifts of the CTV in
anterior-posterior and superior-inferior direction. Note that we
disregarded shifts in left-right direction as well as any rotations
and deformations of the prostate. Previous studies have indicatedthat these anatomical changes are comparably small and less
impactful on the delivered dose [20]. Consequently, we discarded
the coronal and transversal 2D cine MR images. The sagittal 2D
cine MR images were affected by saturation band artifacts, mani-
festing themselves as dark stripes at the intersection of the imag-
ing planes [21]. In order to mitigate the influence of these
artifacts on the following image processing steps, we used a
heuristic intensity correction [22]. We characterized the signal loss
profile by acquiring MR images of a water tank using the same 2D
cine MR sequence. The signal in the affected regions of the patient
images was multiplied by the inverse signal loss profile. Further-
more, the first frame of each 2D cine MR sequence was discarded
as this image is darker than the remaining images.
In order to determine the prostate shift between acquisition of
the 3D verification image and the first 2D cine MR image, the
images had to be further pre-processed. The 3D verification image
was tri-linearly interpolated to match the position and resolution
of the 2D MR images (see previous section and Supplemental
material). Afterwards, the shift of the CTV was determined using
a template matching algorithm [23]. A rectangular template was
automatically extracted from the interpolated verification image
by growing the bounding box of the CTV by 20 mm. The template
matching algorithm then iteratively calculated the similarity
between the template and a section of the 2D cine MR image.
The search region of the 2D cine MR image encompassed the orig-
inal CTV position as well as 25 mm in each direction and was sam-
pled with a grid mandated by the image pixel size. Mutual
information was used as similarity metric as it is robust against
the different imaging contrasts of the T2-weighted 3D MR image
and T2/T1-weighted 2D cine images [24]. The position yielding
the highest similarity was deemed the current CTV position at
the beginning of 2D cine MR imaging.
The motion trajectory during 2D cine MR imaging was also
measured using a template matching algorithm. The first 2D image
of the sequence was used to create a rectangular template by
expanding the bounding box of the CTV by 6 mm. In order to find
the CTV position in the subsequent frames, we defined a search
region with a margin of 20 mm and used normalized cross correla-
tion as similarity metric [25].
The position of the prostate at each time point during dose
delivery was calculated by adding the determined CTV shift
between acquisition of the verification image and 2D cine MR
imaging to the continuous motion trajectory detected during 2D
cine MR imaging. In all cases, we visually assessed the performance
of the image processing algorithms to rule out gross failures.Dose reconstruction workflow
The deployed dose reconstruction workflow evolved from a set
of tools that were originally developed to validate real-time dose
accumulation methods [26]. It aims at calculating the delivered
dose by combining continuous information about the treatment
machine status with a dynamic model of the patient anatomy
(see Fig. 1).
The Unity MR-linac status was recorded every 40 ms. The
machine log files included the treatment beam state (on or off),
deliveredmonitor units, gantry angle and the multileaf collimator’s
leaf and jaw positions. Each log entry was interpreted as a dis-
cretized fluence package that was delivered to the specific patient
anatomy encountered at the time of delivery. In this study, we
modeled the changing anatomy by rigidly shifting the entire veri-
fication image according to the previously extracted prostate
motion trajectory [3,27]. Machine log file and motion trajectory
were synchronized based on their time stamps and the trajectory
was linearly interpolated to match the time points of the MR-
linac log file. Afterwards, the isocenter of each fluence package
Fig. 1. Flow chart describing the dose reconstruction workflow.
Fig. 2. Analysis of the observed prostate motion. The histograms on the left present the shift occurring between the acquisition of the 3D verification images and the
beginning of 2D cine MR imaging. The trajectories on the right denote the mean shift at each time point during 2D cine imaging. The shaded area denotes one standard
deviation in either direction across all fractions per patient.
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treatment beam. In order to reduce the number of fluence packages
to a workable amount, those with similar isocenters, beam angles
and multileaf collimator shapes were grouped together. Fluence
packages were deemed similar using binning sizes of 1.19 mm
(the pixel size of the 2D MR images) for the isocenter positions,
1 for the beam angle and 0.5 mm difference in a single leaf posi-
tion for the different aperture shapes.
The resulting beam set was imported into the Elekta Monaco
treatment planning system, research version 5.59.02, via a soft-
ware tool based on a vendor-provided C++ research interface. The
beam set was encoded as a single step-and-shoot IMRT treatment
plan with multiple isocenters. This approach allowed us to effi-
ciently calculate the delivered dose on the verification image using
a clinically validated dose calculation engine and MR-linac
machine model including the 1.5 T magnetic field [28,29]. The dose
was calculated as dose-to-medium on a grid of 0.25  0.25  0.25
cm3 with a statistical uncertainty of 1%.Evaluation
We analyzed data from the first five prostate cancer patients
treated with the Unity MR-linac at our institute. Of the 100 deliv-
ered fractions, we were able to obtain the 3D verification image, 2D
cine MR images and treatment log file in 90 cases. For these frac-
tions, we analyzed the magnitude and characteristics of the pros-
tate motion. We report both the one-off shift of the prostate
between the acquisition of the 3D verification image and 2D cine
MR imaging as well as the motion trajectory of the primary CTV
during 2D cine MR imaging.Fig. 3. Violin plots presenting the difference between the delivered and planned dose, q
probability density of the data points. Additionally, small box plots are included in each
median. The whiskers represent the 1.5 interquartile range.Additionally, we compared the delivered dose calculated by our
dose reconstruction to the planned dose distribution. The simple
patient model used in this study is able to accurately resolve the
dose to the prostate and nearby regions [27]. More distant struc-
tures may move differentially to the monitored target. For this rea-
son, we only evaluated the dose delivered to the primary CTV and
the near-maximum dose to the adjacent organs-at-risk. We report
the minimum dose received by 98% of the CTV (CTV D98%), CTV
D50%, bladder D3% and rectum D3%. To facilitate this analysis, these
structures were contoured on the verification images by an expert
physician.
In this study, we treated each delivered fraction independently
and did not use any interfractional dose accumulation. However,
we do scale all dose changes by a factor of 20 in order to facilitate
an easier comparison to the clinical intent of delivering 60 Gy in 20
fractions.
Results
We successfully reconstructed the delivered dose of the day in
89 out of 90 fractions. In a single case, the template matching algo-
rithm was unable to accurately localize the prostate in the 2D cine
MR images. During this fraction, the patient involuntarily urinated
during treatment. The urine traversing the urethra appeared
brightly in the 2D cine MR images. This large change in image
intensity greatly reduced the accuracy of the template matching
algorithm.
Between the acquisition of the 3D verification image and the
beginning of 2D cine MR imaging, 6.4 min ± 2.3 min (mean  stan-
dard deviation) passed. In this time, the CTV moved by 0.5 mm ± 1.uantified via four dose-volume metrics. The width of each violin is governed by the
violin. The box marks the first and third quartile, while the white dot denotes the
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tion (see Fig. 2). Afterwards, patients were surveyed with 2D cine
MR imaging for 5.5 min ± 0.8 min. During this time, in which the
radiation beam was turned on, an additional shift of 0.0 mm ± 0.
8 mm along the anterior-posterior axis and 0.1 mm ± 0.9 mm in
inferior direction was detected. Extrapolating the dose changes in
each case to all 20 fractions, the mean CTV D98% and CTV D50%
dose-volume metrics decreased by 1.1 Gy ± 1.6 Gy and 0.1 Gy ± 0.
2 Gy, respectively (see Fig. 3). Bladder D3% did not change (0.0 G
y ± 1.2 Gy), while rectum D3% decreased by 1.0 Gy ± 2.0 Gy.
Both the observed prostate motion and its dosimetric impact
were small in the majority of cases. Detected CTV position andFig. 4. Summary of patient #2, fraction 19. The top row shows the planned dose, recon
measured CTV motion trajectory is shown in the bottom row. Areas shaded in gray den
Fig. 5. Summary of patient #4, fraction 17. The top row shows the planned dose, recon
measured CTV motion trajectory is shown in the bottom row. Areas shaded in gray dendosimetric evaluation of a typical fraction are shown in Fig. 4. In
the presented case, the CTV did not shift by more than a single
pixel (1.19 mm). Consequently, the delivered dose distribution
was very similar to the planned dose and all investigated dose-
volume metrics remained constant.
However, in a few cases the CTV moved substantially after the
final treatment plan was approved on the verification image.
Fig. 5 depicts a fraction with large intrafractional motion. Initially,
the prostate did not shift between the acquisition of verification
image and beginning of 2D cine MR imaging. After the first two
treatment beams were delivered, air bubbles passed through the
rectum. Over the course of the delivery, the CTV’s mean shift wasstructed delivered dose and dose difference overlaid over a sagittal MR-image. The
ote times during which the treatment beam was turned on.
structed delivered dose and dose difference overlaid over a sagittal MR-image. The
ote times during which the treatment beam was turned on.
Fig. 6. Summary of patient #1, fraction 5. The top row shows the planned dose, reconstructed delivered dose and dose difference overlaid over a sagittal MR-image. The
measured CTV motion trajectory is shown in the bottom row. Areas shaded in gray denote times during which the treatment beam was turned on.
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Despite the large observed motion, the delivered CTV dose changed
only slightly. Bladder D3% and rectum D3% increased by 0.8 Gy and
0.4 Gy, respectively.
Another case with large intrafractional prostate motion is pre-
sented in Fig. 6. At the beginning of 2D cine MR imaging the pros-
tate had already moved by 2.38 mm in posterior and 1.19 mm in
inferior direction relative to the verification image. While it
remained stable during treatment delivery, the offset affects dose
coverage of the CTV. Extrapolated to 20 fractions, CTV D98%
decreased by 4.6 Gy and CTV D50% decreased by 0.2 Gy. Simultane-
ously, bladder D3% decreased by 1.5 Gy.
Discussion
In this study, we have presented an end-to-end pipeline to har-
ness the on-board imaging capabilities of an MR-linac to recon-
struct the delivered radiotherapy dose. By processing 3D MR
images, 2D cine MR images and treatment machine log files, we
were able to measure the intrafractional motion and determine
its dosimetric impact in 89 prostate radiotherapy fractions. Con-
trary to previous dose reconstruction methods, our workflow
requires neither the implantation of fiducial or electromagnetic
markers nor extra imaging time associated with increased patient
discomfort and radiation exposure [3,30]. In most cases, we found
the observed anatomical changes and their effect on the dose distri-
bution to be small and most likely clinically irrelevant. However, in
a few fractions large intrafractional motion caused the dose distri-
bution to substantially deviate from the intended plan. Anatomical
changes resulted in underdosage of the CTV or additional exposure
of the rectum and bladder. Considering the full radiotherapy treat-
ment is delivered over 20 fractions, these deviations arguably only
have a negligible effect on clinical outcomes. However, with an
increased interest in hypofractionated and stereotactic radiother-
apy, dose distortions in a single fraction may become more impact-
ful and important to monitor [31].
Our presented workflow deploys a simple template matching
algorithm to detect rigid shifts in prostate position in 2D cine MR
images acquired during treatment. The changing patient anatomyis modeled by rigidly shifting a 3D MR image acquired prior to
treatment delivery. This patient model is not able to resolve rota-
tions, deformations and density changes affecting the radiation
beam’s attenuation. Furthermore, the 2D cine MR sequence used
in our clinical workflow consists of three orthogonal imaging
planes. As our pipeline only processes the sagittal slice, this
imposes an artificial handicap on both the imaging frequency
and the accuracy of the template-matching algorithm caused by
saturation band artifacts. Nonetheless, we believe that our
approach is able to accurately derive the delivered dose to the
CTV and adjacent parts of the bladder and rectum.
In theory, the presented workflow can be extended to account
for rotations by adapting the template-matching algorithm to
detect these and rigidly rotate the planning 3D MR image during
dose calculation [32]. A more sophisticated anatomical representa-
tion is needed to apply the dose reconstruction workflow to cancer
sites that are affected by strong deformations. 2D MR images, as
used in this study, are unable to provide a continuous 3D model
of the patient’s anatomy on their own. In the future, fast 3D MR
acquisition and reconstruction techniques or dynamic patient
models may be able to provide a full volumetric representation
of the patient over the course of radiation delivery [33–35]. Owing
to the modular nature of our presented workflow, such 3D infor-
mation could be seamlessly integrated into our dose reconstruc-
tion tool in the future. However, use of a dynamically updated
patient anatomy requires reliable methods to deformably map
the dose delivered at each time point to a reference image [36].
The ability of MR-guided treatment machines to continuously
survey the patient can also be used to guide real-time adaptive
radiotherapy, such as beam gating or multileaf collimator tracking
[37,15,38]. Dose reconstruction may be used to assure the correct
functioning of these techniques or evaluate their effect on the
delivered dose [39]. All relevant information needed to describe
these techniques, such as the multileaf collimator’s aperture
shapes and the treatment beam status, is already being recorded
in the MR-linac log files and can be processed by our developed
pipeline.
We have presented a dose reconstruction workflow based on
data routinely acquired during MR-guided radiotherapy. We have
94 Automatic reconstruction of the delivered dose with an MR-linacdemonstrated its ability to reliably, non-invasively and automati-
cally reconstruct the delivered dose in 89 prostate radiotherapy
fractions. As more and more imaging information becomes avail-
able, we envision this workflow to be extended to other cancer
sites and ultimately to enter widespread clinical use.
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